Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Treasury Shares: 2018-2021

Historic Treasury Shares for Black Diamond Therapeutics (BDTX) over the last 1 years, with Sep 2021 value amounting to $30,667.

  • Black Diamond Therapeutics' Treasury Shares fell 48.31% to $30,667 in Q3 2021 from the same period last year, while for Sep 2021 it was $30,667, marking a year-over-year decrease of 48.31%. This contributed to the annual value of $18,120 for FY2020, which is N/A change from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Treasury Shares of $30,667 as of Q3 2021, which was down 39.88% from $51,007 recorded in Q2 2021.
  • Black Diamond Therapeutics' Treasury Shares' 5-year high stood at $132,645 during Q4 2018, with a 5-year trough of $18,120 in Q4 2020.
  • In the last 2 years, Black Diamond Therapeutics' Treasury Shares had a median value of $51,007 in 2021 and averaged $43,693.
  • Data for Black Diamond Therapeutics' Treasury Shares shows a maximum YoY plummeted of 48.31% (in 2021) over the last 5 years.
  • Black Diamond Therapeutics' Treasury Shares (Quarterly) stood at $132,645 in 2018, then reached $18,120 in 2020, then plummeted by 48.31% to $30,667 in 2021.
  • Its Treasury Shares stands at $30,667 for Q3 2021, versus $51,007 for Q2 2021 and $59,338 for Q1 2021.